Quick Answer
VERTEX PHARMACEUTICALS INC / MA reported Earnings Per Share Diluted of $15.32 per share for the year ending 2025.
- VERTEX PHARMACEUTICALS INC / MA showed an increase of +836.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from VERTEX PHARMACEUTICALS INC / MA's annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), VERTEX PHARMACEUTICALS INC / MA's Earnings Per Share Diluted has grown by 568.5%.
- Historical annual values: Fiscal year 2025: $15.32 per share | Fiscal year 2024: $2.08 (loss) per share | Fiscal year 2023: $13.89 per share | Fiscal year 2022: $12.82 per share | Fiscal year 2021: $9.01 per share | Fiscal year 2020: $10.29 per share | Fiscal year 2019: $4.51 per share | Fiscal year 2018: $8.09 per share | Fiscal year 2017: $1.04 per share | Fiscal year 2016: $0.46 (loss) per share | Fiscal year 2015: $2.31 (loss) per share | Fiscal year 2014: $3.14 (loss) per share | Fiscal year 2013: $1.98 (loss) per share | Fiscal year 2012: $0.50 (loss) per share | Fiscal year 2011: $0.14 per share | Fiscal year 2010: $3.77 (loss) per share | Fiscal year 2009: $3.71 (loss) per share | Fiscal year 2008: $3.27 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: